← Leaderboards
Wen Y Chen
Clemson University
$571,379
Attributed
$571,379
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $87.4K · FY2005–09$100K$75K$50K$25K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$571,379 · 7
By mechanism
M01$214,379 · 5
R21$210,000 · 1
R03$147,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Clemson University
Same institution · by research overlap
- Amy Hairston Crockett$2,955,725
- Jeoung Soo Lee$2,234,558
Others in their field
Top investigators on “Breast Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$251,848,784
- Richard L Schilsky · University Of Chicago$110,812,897
- Walter John Curran · Thomas Jefferson University$96,881,565
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$87,504,493
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,613,341
Research focus
Breast NeoplasmsProlactinHormone InhibitorOvarianLungOncologyKidneyBreastGrantInstitutionBloodCarcinomaBody FluidsMalignant NeoplasmsAntigensBrainColonComputer Retrieval Of Information On Scientific Projects DatabaseHead And Neck StructureBladderFundingCancer DiagnosisCancer PatientLaboratories
Grant awards (9)
CLINICAL TRIAL: EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/ SURFACE PR$5,479
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/ SURFACE PR$7,104
M01 · FY2008 · RR · contact PI
EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/ SURFACE PROTEASE ANTIGE$41,602
M01 · FY2007 · RR · contact PI
EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/$87,446
M01 · FY2006 · RR · contact PI
EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/ SURFACE PROTEASE ANTIGENS$72,748
M01 · FY2005 · RR
Human Prolactin antagonist as a Chemopreventive Agent$73,500
R03 · FY2004 · CA
Human Prolactin antagonist as a Chemopreventive Agent$73,500
R03 · FY2003 · CA
IN VIVO STUDIES OF A PROLACTIN ANTAGONIST IN SCID MOUSE$105,000
R21 · FY2001 · CA
IN VIVO STUDIES OF A PROLACTIN ANTAGONIST IN SCID MOUSE$105,000
R21 · FY2000 · CA